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Hepatocellularcarcinoma(HCC)isoneoftheleadingcausesofcancer-relateddeathsworldwide.HepatitisBorCinfectionsarethe
maincausesofHCCwithhepatitisCbeingthemajorriskfactorforlivercancerinthedevelopedcountries.Recently,complications
with bacteria of the genus Helicobacter have been associated with HCV-induced HCC. To further understand the mechanisms
leading to the development of HCC in the presence of HCV and/or Helicobacter spp., investigation of the diﬀerential protein
expression in Huh7 cells harbouring HCV-replicon, and replicon cured-Huh7 cells cocultured with H. bilis was done employing
two-dimensionalgelelectrophoresisandmassspectrometry.Inthetransfected-Huh7cellsexposedtosublethalinoculumdensities
of H. bilis,5 3d i ﬀerent proteins were identiﬁed comprising of 28 upregulated and 16 downregulated proteins including 9 potential
protein isoforms; in the cured Huh7 cells, 45 diﬀerent proteins were identiﬁed including 33 upregulated, 8 downregulated and,
9 potential protein isoforms. H. bilis aﬀected the modulation of proteins involved in diﬀerent pathways of Huh7-derived cells
physiology including proteins involved in the progression from dysplasia to neoplasm. The result also indicated that the response
of the Huh7-derived cells to the presence of H. bilis depended on whether or not HCV replicon was present.
1.Introduction
Hepatocellular carcinoma (HCC) is a malignancy of the liver
caused by cirrhosis, the scarring of liver tissues. Cirrhotic
liver results from chronic inﬂammation generally attributed
to chronic and persistent infections of the liver by Hepatitis
B virus (HBV) Hepatitis C virus (HCV), or alcohol abuse.
Other carcinogens that have been associated with HCC
include the Aspergillus aﬂatoxin B1, hemochromatosis, and
fatty liver disease related to diabetes and obesity, but their
frequenciesofassociationwiththelivercancerarelowerthan
HBV or HCV.
Many of the chronic carriers of HBV or HCV do not
develop cirrhotic liver, and only a subset of patients suﬀering
from the viral-induced liver cirrhosis eventually progress to
HCC, suggesting the existence of cofactors in hepatocarcino-
genesis in the presence of HBV or HCV. For example, alcohol
liver disease (ALD) has been documented as potentiating the
development of the liver tumour in the presence of HBV or
HCV [1], and syngergistic interactions between aﬂatoxin B1
and HBV have been reported in HCC [2]. In addition,
information supports that coinfection with HBV and HCV
increases the risk of HCC development over that with either
viruses alone, and the increased risk is additive [3].
Recent information suggests the existence of bacteria
cofactor in the progression of chronic viral hepatitis to cir-
rhosis and HCC. Bacteria DNA belonging to the Helicobacter
genus have been increasingly identiﬁed in tissue specimen
from patients suﬀering from HCV-induced HCC [4–7].
Further,inseveralHCVpositivepatientsatdiﬀerentstagesof
thediseaseprogression,Helicobacter DNAwasfoundin4.2%
of the controls and 3.5% of the patients with noncirrhotic
chronic hepatitis compared to 61–68% in cirrhotic liver and2 International Journal of Hepatology
90% in HCC tumoural tissue [8]. At diﬀerent stages of the
disease, the strength of association between the presence of
Helicobacter DNA and the disease increased with severity
of the cancer [8], suggesting that infections by Helicobacter
spp. at some stage in the HCV-induced liver cirrhosis may
contribute to the progression from dysplasia to neoplasia.
The molecular mechanisms involved in the progression to
cirrhosis and HCC in some patients suﬀering from HCV-
inducedhepatitisisstillpoorlyunderstood,andthepotential
roles that Helicobacter spp. may play in HCC is largely
unknown.
Helicobacter species cause persistent and chronic infec-
tions in their host cells where they induce strong inﬂam-
matory responses [9, 10]. Given the role played by chronic
inﬂammation in malignant diseases in general, and specif-
ically in cirrhosis and HCC, and considering reports of
greater degree of hepatic damage [11] and higher incidence
of cirrhosis [12] in dual infection of both HBV and HCV, or
infection of either virus in a background of ALD or aﬂatoxin
B1 intoxication, the coinfection of HCV and Helicobacter
spp. may have a role in the development of liver malignancy.
These coinfections may be one of the triggers required for
the progression from cirrhosis to cancer in HCV-induced
HCC. The association between HCC and Helicobacter spp.
is further enforced by the ﬁnding that H. hepaticus induces
chronic active hepatitis and HCC in A/JCr mice [13, 14], as
well as the classiﬁcation of H. pylori as a human carcinogen
[15]. In this study, the eﬀects of H. bilis on the proteome
of Huh7 cells harbouring HCV replicon (transfected Huh7)
and in replicon-cured Huh7 cells (cured Huh7 cells) were
investigated.
Helicobacter bilis is a Gram-negative microaerophilic ba-
cillus with urease, catalase, and oxidase activity, and a mem-
ber of the enterohepatic Helicobacter species (EHS) that gen-
erally colonize the intestines, and livers of animals and birds.
Helicobacter bilis colonizes the gall bladder, lower intestine
and liver of mice where it causes chronic hepatitis and
HCC [16, 17]. Human hepatoma Huh7 is a well-differenti-
ated liver epithelial cell line that is used commonly in the in
vitro studies of the liver and its associated diseases [18]. In
this study, Huh7 cells not cocultured with H. bilis served as
controls; thus, comparative analysis between the experimen-
tal and control cell population will reveal the eﬀects of the
bacteria, notwithstanding that malignant transformation is
already present in the hepatoma cells. The Huh7 transfection
with Nneo3–5B (RG) is stable and permits the replication of
HCV subgenomic replicon. The cured Huh7 is the rescued
transfected Huh7 by treatment with interferon alpha (IFN-
α).
Global analyses of the proteome of cells grown under dif-
ferent conditions provide important information about the
physiological processes that take place in the cells, the iden-
tiﬁcation of new cancer biomarkers and disease-associated
targets, and pathogenic processes. Proteomic analyses have
been employed to study changes in protein expression
related to carcinogenesis [19, 20]. In the present study,
two-dimensional polyacrylamide gel electrophoresis was
employed to analyse the global protein expression proﬁles
of cytosolic proteins obtained from the two Huh7-derived
cell lines cocultured with and without H. bilis. Identities of
diﬀerentially expressed proteins were determined by tandem
mass spectrophotometry. Additionally, real-time polymerase
chain reaction was employed to determine the diﬀerential
expression of known HCC-related genes by the Huh7 cell
lines in response to H. bilis.
2.MaterialsandMethods
2.1. Growth Conditions. The transfected and cured Huh7
cells were kind donations from Professor Peter White labo-
ratory, School of Biotechnology and Biomolecular Sciences,
the University of New South Wales, Sydney, Australia. The
cells were transformed following the method of Inoue et al.,
2007 [21], and the cured cells by treating the transfected
cells with IFN-α using the method of Ikeda et al., 2002 [22].
The cells were maintained at 37◦C in Dulbecco’s Modiﬁed
Eagle Medium (DMEM), containing 25mM D-glucose, and
4.0mM of Glutamax (L-alanyl-L-glutamine) as a substitute
for L-glutamine (Invitrogen, Mulgrave, Vic, Australia), and
supplemented with 10% Neonatal Calf Serum (NCS) (Invit-
rogen; Australia). Prior to cocultures with H. bilis,c e l l sw e r e
cultured in a 75cm2 vented tissue culture ﬂasks (Interpath
Services; Caringbah, NSW, Australia) under an atmosphere
of 5% CO2 until ca. 50% conﬂuency, and adapted for 6h to
the coculture media, which consisted of 9.25g/L Brain Heart
Infusion (BHI) (Oxoid, Australia), 10% (v/v) Horse Serum
(Oxoid, Heilderberg, Vic, Australia), 10% (v/v) NCS and
80% (v/v) DMEM.
Helicobacter bilis strain ATCC 51630 was grown in Cam-
pylobacter Selective Agar (CSA), consisting of Blood Agar
Base No. 2 (Oxoid; Australia), supplemented with 5% (v/v)
deﬁbrinated horse blood (Oxoid, Australia). The media con-
tained 2μg/mL fungizone (Bristol-Myers Squibb; Sydney,
NSW, Australia), 0.32μg/mL polymixin B, 5μg/mL trime-
thoprim, and 10μg/mL vancomycin (Sigma; North Ryde,
NSW, Australia). Bacterial cultures were incubated for 48h
at 37◦C under the microaerobic conditions of 5% CO2,5 %
O2 and 90% N2.
To study the eﬀects of H. bilis on the transfected and
cured Huh7 cells, bacteria were harvested from plates and
grown for 6h in the coculture media. Prior to cocultures
with the human cells, the bacteria were washed in BHI broth
and resuspended to a density of OD600 ∼1.00. Appropriate
volumes of H. bilis were inoculated into the semiconﬂuent
hepatoma cell cultures at densities of upto 1010 cfu/mL. The
cocultures were incubated at 37◦C for 48h under an atmo-
sphere of 5% CO2,5 %O 2, and 90% N2. Control cultures,
consisting of hepatoma cells in coculture media without bac-
teria were grown under the same conditions. Comparison
of the growth of the hepatoma cells between microaerobic
conditions and normal atmosphere of 5% CO2, 19% O2,
and 78% N2 was also carried out. After 48h incubation,
cell morphology was examined by inverted microscopy.
The culture media was poured oﬀ from the vented ﬂasks
and cell monolayers were gently washed three times with
sterile phosphate buﬀered saline (pH 7.6) to remove the
bacteria from the cocultures containing H. bilis.T od e t a c h
the cells, the ﬂasks were ﬂooded with 5mL of Trypsin/EDTAInternational Journal of Hepatology 3
(0.13%/0.03%), and incubated at 37◦Ci n5 %C O 2 for
approximately 20min or until the cells were detached. The
live/dead status of the Huh7 cells was determined by trypan
blue staining to assess cell viability, and the number of live
cells was counted using an improved neubauer cytometer.
Bacterial growth was measured at 48h and the morphology
andpurityoftheculturesweredeterminedbyphase-contrast
microscopy. Bacteria were grown on CSA plates to examine
the creamy characteristics.
2.2.PreparationofProteinSamples. Todeterminediﬀerential
protein expression, the Huh7-derived cells were grown in
coculture media under a microaerobic atmosphere at 37◦C
without bacteria or with 103 cfu/mL H. bilis. After 48h incu-
bation, the transfected and cured Huh7 cells were detached,
harvested by centrifugation at 1000×gf o r2 5 m i na t4 ◦C,
washed thrice with 30mL 0.2M ice cold sucrose, mixed by
pipetting, and centrifuged again at 1000×gf o r2 5 m i na t
4◦C. The resulting cell pellet was collected, resuspended in
1mLTSUbuﬀer, and disrupted on ice by sonication with a
Branson digital soniﬁer (Branson Ultrasonics Corporation;
Danbury, CT, USA) at amplitude of 30% for 15s at a 5s
pulse and 5s delay between pulses. This was repeated 15
times, and resulting suspension was centrifuged at 14000×g
for 20min at 4◦C to remove cell debris, the supernatant
was collected and nucleic acids were removed by adding
10μL nuclease buﬀer and incubating for 20min at 4◦C.
Aliquots of the protein cell-free extracts were stored at –80◦C
for a maximum of three months or until used for 2D-gel
electrophoresis.
The protein concentration of cell-free extracts was esti-
matedbythebicinchoninicacidassayemployingamicrotitre
protocol (Pierce, Rockford, IL, USA). Optical densities were
measured at 595nm using a Beckman Du 7500 spectropho-
tometer to determine the absorbances of the copper com-
plexes in both samples and standards. The protein concen-
tration of each sample was calculated based on a calibration
curve constructed with known concentrations of BSA.
2.3. Two-Dimensional Gel Electrophoresis and Image Analyses.
Two-dimensional polyacrylamide gel electrophoresis (2D-
PAGE) was performed as previously described [23]w i t h
some modiﬁcations. In the ﬁrst dimension, an aliquot con-
taining 150μgo fp r o t e i nw a sm a d eu pt oaﬁ n a lv o l u m eo f
250μL in freshly prepared rehydration buﬀer containing 8M
urea, 100mM dithiothreitol (DTT), 65mM 3-[(3-cholamid-
opropyl)-dimethyammonio]-1-propanesulfonate (CHAPS),
40mM Tris-HCL, pH 8.0, and 10μLo fp H4 – 7I P Gb u ﬀer.
Samples were centrifuged at 14000×ga t4 ◦Cf o r2 0 m i n
to clarify the supernatants and were loaded onto an 11cm
immobiline dry strip pH 4–7 (Bio-Rad; Regents Park, NSW,
Australia) in an immobiline tray. Isoelectric focusing was
performed at 14◦C using the IsoelectrIQ2 (Proteome Sys-
t e m s ;N o r t hR y d e ,N S W ,A u s t r a l i a ) ,p r o g r a m m e da t3 0 0V
fast voltage ramp for 4h, 10,000V linear voltage ramp for
8h, and 10,000V fast/linear voltage ramp for 12h, or until
120,000Vh were reached. Following isoelectric focusing,
strips were equilibrated in two buﬀers containing 6M urea,
20% (v/v) glycerol, 2% (w/v) SDS, 375mM Tris-HCl; the
ﬁrst with 130mM DTT and the second with 135mM iodo-
acetamide (IA).
In the second dimension, sodium dodecyl sulphate-pol-
yacrylamide gel electrophoresis (SDS-PAGE) was performed
on criterion system precast 12.5% acrylamide gels (Bio-Rad,
Australia)at14◦Cand50Vfor1h,followedby64mAfor2h
or until the bromphenol blue dye front reached the bottom
of the gels. Gels were ﬁxed separately in 100mL of ﬁxing
solution (50% v/v methanol, 10% v/v acetic acid) with gentle
shaking for a minimum of 0.5h, stained employing a silver
stainingmethod[24],andimagedusingaUmaxPowerLook-
1000 ﬂatbed scanner (FujiFilm; Tokyo, Japan). For compar-
ative gel-image analysis, data were acquired and analyzed
using the Z3 software package (Compugen; Jamesburg, NJ,
USA). Statistical analyses (Student’s t-test, 95% conﬁdence
interval) were performed on three gels from each growth
conditions (experimental versus control) to determine the
diﬀerential spot intensities between both conditions. In the
analyses, a gel from cells grown without bacteria served as
the reference gel; master gels were compiled from three gels
of each growth condition, and were compared to determine
the relative intensities of each protein spot.
2.4. Mass Spectrometry Identiﬁcation of Proteins. Protein
spots showing two-fold or more diﬀerences in intensity
between both experimental conditions were cut out of the
gels and washed twice for 10min in 200μL of 100mM
NH4HCO3, reduced at 37◦Cf o r1 hw i t h5 0 μLo f1 0 m M
DTT, alkylated for 1h in 50μL of 10mM IA, washed for
10min with 0.2mL of 10mM NH4HCO3,d e h y d r a t e di n
acetonitrile, and trypsin-digested with 10ng/μL of trypsin
(Promega; Annandale, NSW, Australia). After digestion for
1 4 ha t3 7 ◦C, peptides were extracted by washing the gel
slice for 15min with 25μL 1% formic acid, followed by
dehydrationinacetonitrile. Digestswerethendried invacuo,
resuspended in 10μL 1% formic acid and separated by nano-
LC using an Ultimate/Famos/Switchos system (LC Packings,
Dionex; Lane Cove, NSW, Australia). Samples (5μL) were
loaded on to a C18 precolumn (Micron; 500μm × 2mm)
with buﬀer A (98% H2O, 2% CH3CN, 0.1% formic acid)
and eluted at 25μL/min. After a 4min wash, the ﬂow
was switched into line with a C18 RP analytical column
(PEPMAP; 75 lm × 15cm) and eluted for 30min using
buﬀe rAa t2 0 0 μL/min. The nano-electrospray needle was
positioned ∼1cm from the oriﬁce of an API QStar Pulsar
tandem mass spectrometer (ABI; Foster City, CA, USA). The
QStar instrument was operated in information-dependent
acquisitionmode.Atime-of-ﬂightmassspectrometrysurvey
scan was acquired (m/z350–1700, 0.5s), and the two largest
precursors (counts >10) were selected sequentially by Q1
for tandem MS analysis (m/z50–2000, 2.5s). A processing
script generated data suitable for submission to database
searchprograms.Collisioninduceddissociationspectrawere
analysed using the Mascot MS/MS ion search engine (Matrix
Sciences; Boston. MA, USA) with the following parameters:
trypsin digestion allowing up to one missed cleavage, oxida-
tionofmethionine,peptidetoleranceof0.25Da,andMS/MS
toleranceof0.2Da.SearcheswereperformedontheNational4 International Journal of Hepatology
CentreforBiotechnology Informationnonredundant (NCBI
nr) database.
2.5. Real Time Polymerase Chain Reaction (qRT-PCR). Total
RNA was extracted from transfected- and cured Huh7 cells
using the TRIzol reagent (Invitrogen, Australia) according
to the manufacturer’s instructions. The optical density mea-
suredat260nm wasemployed todetermine RNA concentra-
tions; and RNA purity was veriﬁed by measuring the optical
density ratios, OD260/OD280 and OD260/OD230 using a
NanoDrop ND-1000 spectrophotometer (Biolab; Mulgrave,
VIC, Australia). RNA samples with OD260/OD280 < 1.8 or
OD260/OD230 < 1.9 were further puriﬁed by overnight
ethanol precipitation at –20◦Ci n3Ms o d i u ma c e t a t e( p H
5.2). Puriﬁed RNA pellets were washed once with 80%
ethanol and resuspended in DEPC-H2O. RNA samples were
stored at –80◦C for three months or until used.
Speciﬁc primers were designed based on the sequences
published in the Human Genome available on the NCBI
database; and employing the primer3 algorithm [http://
www.genome.wi.mit.edu/genome software/other/primer3]
.html]. The properties of the primers were: melting tem-
peratures between 60–63◦C, length 19–23bp, G-C content
50–55%, and expected size of the product 200–210bp. The
primer sequences used in this study is available on request.
To study the diﬀerential expression of genes reported to
beassociatedwithHCC,totalRNAextractedfromtheHuh7-
derived cells exposed to H. bilis was reverse-transcribed
to cDNA using SuperScript III First-strand SuperMix kit
(Invitrogen, Australia). Quantitative real-time PCR analyses
were performed in triplicate using a Corbett Research Rotor
Gene RG-3000 thermal cycler (Corbett Life Science; Sydney,
NSW, Australia), employing the SYBR GreenER qPCR uni-
versal supermix according to the manufacturer’s instructions
(Invitrogen, Australia). Each reaction was performed in an
individual tube in a seventy-two tube strips, containing
12.5μL supermix, 1.0μL of 100ng/μLf o rw a r dp ri m e r ,1 . 0μL
of 100ng/μL reverse primer, 1.0μL of 100ng/μL of cDNA,
and DEPC-treated water to a total volume of 25μL. As
controls, reactions were also run in the absence of template
cDNA to detect any contamination for each primer set.
Conditions for the qRT-PCR were 2min at 50◦C, 10min
at 95◦C and 40 cycles each consisting of 15s at 95◦C, and
40s at 60◦C, and acquiring ﬂourescence at 76◦Cf o r1 5 s .
At the completion of the PCR run, the temperature was
increased from 72◦Ct o9 5 ◦C for 115s; the ﬂourescence
was measured continuously to construct melting curves. The
relative expression of each target gene was normalized to the
glyceraldehyde 3-phosphate dehydrogenase (GAPDH) gene
using the method described by [25]. Brieﬂy, the crossing
points (CP) for each target gene were normalized to the
geometricmeanCPofthehousekeepinggeneemployingthe
following expression:
Ratio =

ETarget
ΔctTarget(Control-Sample)
(EReference)
ΔctReference(Control-Sample), (1)
where E is the ampliﬁcation eﬃciencies of target and
reference genes, assumed in this study to be 2 for all
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Figure1:Growthoftransfected-andcuredHuh7cellsincocultures
with H. bilis at diﬀerent inoculum densities. The initial number
of Huh7 cells determined by the improved Neuber cytometer after
staining with trypan blue was ca. 105.5 cells/ml. The number of
viable Huh7 cells counted after 48h in cocultures with H. bilis are
shown in the ﬁgure. The values represent the mean count of Huh7
cells from three independent experiments.
genes [26], and Ct is the comparative threshold cycle. The
control/sample values were obtained with template cDNA
from transfected- and cured Huh7 cells without bacteria and
those exposed to sublethal H. bilis density of 103 cfu/mL.
3. Results and Discussion
3.1. Growth of Huh7-Derived Cell Lines in CoCultures with
H. bilis. In the transfected- and cured Huh7 cells cocultured
with H. bilis, hummingbird morphology was observed at
bacterial densities of 103 cfu/mL and higher. The results also
revealed no signiﬁcant (P>0.05) decline in cell proliferation
between the transfected and cured Huh7 cells (Figure 1),
suggesting that neither the presence of the HCV-replicon nor
its inactivation by IFN-α treatment aﬀected diﬀerently the
morphology and growth-response of the liver cells to the
stress exerted by the presence of H. bilis. This phenomenon
was similar to that observed in the parent Huh7 cells
describedpreviously(manuscriptsubmittedelsewhere).This
study did not investigate the response of the hepatoma cells
to IFN-α treatment in the presence of H. bilis although it
is acknowledged that the cured cells could also present the
eﬀects of IFN-α.
3.2. Diﬀerential Expression of Proteins by the Transfected- and
Cured Huh7 Cell Lines in response to H. bilis. Total proteins
from transfected- and cured Huh7 cells cultured in the
presence and absence of H. bilis were extracted, puriﬁed, and
separated in two dimensions employing a pH gradient of
4–7 for the ﬁrst dimension, and an 11.5% SDS acrylamide
gel in the second dimension. The intensities of protein
spots from transfected- and cured Huh7 cells grown in the
presence and absence of H. bilis were determined. Spots
with diﬀerential intensities equal to or greater than 2-foldInternational Journal of Hepatology 5
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Figure 2: 2D-PAGE gels showing spots of soluble proteins of transfected and cured Huh7 cells in the pI 4–7 range. Gels (a) and (b)
correspond to proteins of transfected Huh7 cells, gels (c) and (d) correspond to proteins of cured Huh7 cells. Cells were incubated in
the presence of an initial H. bilis inoculum of approximately 103 cfu/mL. Protein spots in gels were visualised by silver staining. The spot
intensitiesfromtriplicategelsofthreeindependentexperimentsweredeterminedusingtheZ3computationalsoftware.Spotscorresponding
to proteins diﬀerentially expressed are indicated on the ﬁgure.
between cultures grown with and without bacteria were
considered to be up or downregulated, and identiﬁed by LC-
MS/MS. Figure 2 shows four reference 2D-gels from each
growth condition obtained from at least three independent
experiments. In the transfected Huh7 cells exposed to sub-
lethal inoculum densities of H. bilis, a total of 53 diﬀerent
proteins were identiﬁed comprising of 28 upregulated and
16 downregulated proteins, including 9 potential protein
isoforms; in the cured Huh7 cells/H. bilis cocultures, 45
diﬀerent proteins were diﬀerentially expressed including
33 upregulated, 8 downregulated, and 9 potential protein
isoforms (Table 1). The potential protein isoforms consist of
proteins that were identiﬁed in the same spots as highlighted
in Table 1.
3.3. Biological Functions of the Modulated Proteins of
Transfected- and Cured Huh7 Cell Lines in CoCultures with H.
bilis. The identiﬁed proteins were related to several impor-
tant biological functions, namely, regulation of cell prolif-
eration and structure, metabolism and biosynthesis, protein
translation and modiﬁcation, regulation of transcription,
stress response, signal transduction and transport, and
tumour-related proteins (Table 1).
3.4. Metabolic Enzymes. Hepatocellular carcinoma often ex-
hibits aberrant expression of metabolic enzymes. Various
studies have shown perturbations of host metabolism during
HCV infection [27, 28]. For example, [27] showed perturba-
tions in glycolysis, the pentose phosphate pathway, and the
citric acid cycle during in vitro HCV infection of Huh7.5
cells. In the present study, both transfected- and cured Huh7
cells modulated proteins of various metabolic pathways in
response to H. bilis. The glycolytic enzymes enolase (ENO)
and triosephosphate isomerase (TIM) were upregulated in
the transfected Huh7 cells, and the cured Huh7 cell line also
upregulated TIM, suggesting an upregulation of glycolysis by
both types of cells in response to H. bilis. Upregulation of
glycolysis would provide energy required by the hepatocytes
to resist the stress exerted by H. bilis. Increased glycolysis is
consistent with the upregulation of other enzymes involved
in energy production observed in this study, namely, ATP5B
and ATP5H in the transfected Huh7 cells; and ATP5B in6 International Journal of Hepatology
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the cured Huh7 cells. Similar upregulation of energy pro-
ducing enzymes was observed in our previous study with
the parent Huh7 cells to H. bilis, thus indicating a common
response to H. bilis whether or not HCV replicon is present
in the cell.
The enoyl coenzyme A hydratase 1, ECH1, participates
in fatty acid, propanoate, and tryptophan metabolism. The
enzyme was upregulated in the transfected Huh7 cells but
was not found among the modulated proteins of the cured
Huh7 cells in cocultures with H. bilis. Upregulation of ECH1
could increase the biosynthesis of fatty acid metabolic inter-
mediates required for the maintenance of cell membrane
stability under the stress exerted by H. bilis. It also suggested
mitochondrial stress and hepatic lipid oxidation, both of
which have been linked to liver cirrhosis [29]. Among the
regulated proteins of the cured Huh7 cells cocultured with
H. bilis, was the tryptophan 5-monooxygenase activation
protein YWHAQ, that participates in signal transduction.
Several of the metabolic enzymes identiﬁed in the
transfected Huh7 cells in response to H. bilis presence were
not identiﬁed in the cured Huh7 cells from which the
replicon has been eliminated by IFN-α treatment or in the
previously studied parental Huh7 cells. This indicates a
synergy between the activities of the replicon and H. bilis
on the metabolic pathway of the hepatoma cells. Also, the
diﬀerence in the modulated metabolic proteins between the
parental and cured Huh7 cells suggests the eﬀect of IFN-α
treatment on the cured cells and/or a permanent eﬀect of the
virus on the cells such that it responds H. bilis diﬀerently
from the parental cells; a future study in which an IFN-α
Huh7 cell population is included as a control would serve to
resolve this. Nonetheless, this result is in concordance with
the study of [30] which showed diﬀerences in the response to
HCV infection of na¨ ıve, transfected and cured Huh7 cells.
3.5. Stress Response Proteins. Similarity in the upregulation
of the heat shock proteins and chaperones was observed in
both transfected and cured Huh7 cells in response to H.
bilis.Similarupregulationinbothcellswasobservedwiththe
thio-speciﬁc antioxidant proteins, although peroxiredoxin
3 isoform precursor and peroxiredoxin 4 were identiﬁed
only in the cured cells. Oxidative stress response proteins
were downregulated in the transfected cells, but were not
identiﬁed among the regulated proteins of the cured Huh7
cells. Notably, the 2 thioredoxin proteins identiﬁed were
modulated diﬀerently in both cells: thioredoxin 1 was down-
regulated in the cured cells while in the transfected cells,
the endoplasmic reticulum thioredoxin superfamily member
protein was upregulated.
The data indicated that H. bilis e x e r t e ds t r e s so nt h e
mitochondria resulting in the regulation of mitochondrial-
localised DNAK, CPN60, PRXD3, and SOD proteins. The
upregulation of the endoplasmic-reticulum- (ER-) speciﬁc
TXNDC12 suggested also that an ER stress was exerted on
thetransfectedHuh7cells.Thediﬀerencesinthemodulation
between the transfected- and cured Huh7 cells of stress
response proteins indicated that the presence of the HCV-
replicon aﬀected the molecular response of the hepatocytes
to H. bilis.
This diﬀerence in the responses to H. bilis of the two cells
not containing HCV replicon (parent Huh7 and cured Huh7
cells) suggested a permanent alteration of some cellular
pathways by the virus or by the treatment with IFN-α.
Generally, during the infection of hepatocytes by HCV,
the lipid peroxidation and ROS generated by the hepatic
inﬂammationthatisinducedduetothereleaseofproinﬂam-
matory cytokines [31] could cause breaks in cellular DNA or
mutations in diﬀerent genes [32–34]. These mutations may
result in permanent changes in some cellular pathways even
when the virus has been inactivated. Similarly, treatment
with IFN-α could lead to changes in the Huh7 cells; for
example, changes in the functions of cellular factors were
induced in Huh7 cells following exposure to IFN-α [35];
also, alterations in some signaling pathways of hepatoma
cells treated with IFN-α have been reported [36]. Thus, the
observed diﬀerences in the molecular response of the parent
and the cured Huh7 cells to H. bilis could be the result
of changes in the cells caused by the alterations of cellular
pathways by the virus and/or by exposure to IFN-α.
3.6. Protein Translation, Modiﬁcation, and Degradation. This
category covers proteins that participate in the synthesis,
translation, proper folding of other proteins, and degrada-
tion of misfolded proteins. Given the number and pattern of
modulation of identiﬁed proteins in this category compared
to other categories (overall total number of modulated
proteins = 21. Total from transfected cells = 12: upregulated
= 9, downregulated = 3. Total from cured cells = 13:
upregulated = 11 and downregulated = 2), it is reasonable to
infer that the presence of H. bilis caused major perturbation
in the protein translation, modiﬁcation, and degradation
machineries of the cell. This becomes more apparent when
compared with our data on the eﬀect of the bacterium on
the parent Huh7 cells in which all 7 modulated proteins were
downregulated (data submitted elsewhere).
The upregulation of elongation initiation factor EIFA
in the transfected cells and EIF5A in both the transfected-
and cured Huh7 cells suggested overall increase in protein
synthesis in both cells. The upregulation in both cell types
of the prefolding subunit 2, PFDN2, which also participates
in protein production by ensuring that newly synthesized
polypeptides fold correctly through binding and stabiliz-
ing them, supports the notion that protein synthesis was
upregulated by both cells in response to H. bilis. In the
cured Huh7 cells, the human pre-mRNA splicing factor,
SF2, was also upregulated, but the heterogeneous nuclear
ribonucleoprotein C (HNRP) and mitochondrial ribosomal
protein, MRPL17, which also functions in the stabilization
of newly synthesized polypeptides, were downregulated.
Thus, the downregulation of both HNRP and MRPL17 is
counter intuitive to the notion of increased protein synthesis
of the cells in response to H. bilis. Besides the functions
of HNRPC and MRPL17 in stabilizing newly synthesized
polypeptidesandensuringproperfoldingofnewlytranslated
proteins [37], both proteins are also involved in cellular
apoptotic pathways [37–40]. Their downregulation would
therefore aﬀect the normal programmed death of stressed
and diseased cells, which could induce cell changes leading10 International Journal of Hepatology
to the emergence of mutated cells. Also counter intuitive
to increased protein production in response to the bacteria
wasthedownregulation ofthetranslationelongationfactors,
EEF1D and EEF2D, in the cured Huh7 cells indicating that
the presence of the bacterium aﬀected the normal protein
expression of the cell.
The eﬀect of the bacterium in the normal protein ex-
pression of the cells could result in accumulation of
misfolded and/or mutated proteins. This could explain
the apparent activation by the cells of the the ubiquitin
system, which is primarily involved in protein degradation
[41]. Proteins destined for degradation are tagged with
the ubiquitin protein through a series of enzymatic steps
initiated by an ubiquitin-activating enzyme E1. Following
activation, the ubiquitin is transferred to the ubiquitin-
conjugating enzyme E2, and ﬁnally to a target protein in
a process facilitated by the E3 ligase. Speciﬁc selection for
targets is accomplished by E2 and E3 proteins. UBE2N is a
human mono-ubiquitinated form of ubiquitin-conjugating
enzyme which promotes the polyubiquitination of speciﬁc
targetsthatmodulatetheactivityofvariouscellularprocesses
including DNA repair, mitotic progression, and nuclear
factor-kappaB signaling [42]. Among the various types of E3
proteins SKP1 is a component of the SCF (SKP11/Culin/F-
box protein) ligases. Ubiquilins function as shuttle vectors
to deliver ubiquitinated proteins to the proteasomes in the
endoplasmic reticulum for degradation. In transfected Huh7
cells, the upregulation of the E3 ligase SKP1, the ubiquilin
UBQLN1, and the proteasome proteins PSMA2, PSMA3
and PSMA4 indicated an activation of the ubiquitin system,
although UBE2N was downregulated suggesting a downreg-
ulation of the ubiquitin system at the point of ubiquitin
conjugation. However, other conjugases such as UBE2D1,
which are speciﬁcally associated with the SCF family of
ligases, could salvage the system at the point of ubiquitin
conjugation.
Further evidence of the bacteria eﬀect on the ubiquitin
pathway was the downregulation of ubiquitin carboxyl-ter-
minal hydrolase enzymes, UCHL1, and UCHL3 in both
transfected and cured cells. In addition, upregulation in both
cellsofcathepsinD,(CTSD),anapoptoticregulatoryenzyme
[43], whose upregulation has also been associated with HCC
[44], indicate the perturbation of the apoptotic pathway and
suggests a potential carcinogenic eﬀects of the bacterium.
Compared to the cured Huh7 cells, the transfected Huh7
cellsmodulatedtheexpressionofalargernumberofproteins
involved in protein degradation pathways, probably reﬂect-
ing that H. bilis induced the generation of more abnormal
proteins in the latter cells. This would suggest an exertion
of a greater stress by the bacterium on the transfected Huh7
cells relative to the cured Huh7 cells. Similarly to the cured
Huh7 cells, the parent Huh7 cells modulated fewer proteins
that participate in protein degradation pathways (Data not
shown). Hence, in comparison, H. bilis appeared to have
exerted greater stress on the transfected Huh7 cells.
3.7. Cell Proliferation and Structure. Dysregulation of cell
proliferation represents a protumorigenic principle in
human hepatocarcinogenesis. The transfected- and cured
Huh7 cells modulated a good number of proteins involved
in the regulation of cell proliferation and structure (Table 1).
Vimentin (VIM) is a cytoplasmic intermediate ﬁlament
characteristic of mesenchymal cells usually not expressed
in epithelial cells [45], but was upregulated by both the
transfected- and cured Huh7 cell lines in response to H. bilis.
Gilles and co-workers showed that the atypical expression
of VIM in epithelial cancer cells might be associated
with local invasiveness and metastasis potential [46]. The
overexpression of VIM and its relation to tumor metastasis
have been reported in several carcinomas [47–49], and its
expression in the various cancer cells was essential to the
successive shape change through the interaction with actin
and other intermediate ﬁlaments [50]. Thus, the upregula-
tion of VIM by both the transfected- and cured Huh7 cells
may be correlated to the hummingbird morphology, and
also indicates a carcinogenic eﬀect of H. bilis on the cell
lines.
Related to the regulation of cell structure, cytoskeletal
proteins that control microﬁlament and microtubules were
found among the modulated proteins of the transfected-
and cured Huh7 cells. In both cell lines, beta-actin (ACTB)
was upregulated. The highly conserved ubiquitous ACTB is
regarded as a housekeeping gene involved in the formation
of ﬁlaments that are a major component of the cytoskeleton,
and participates in cell motility, structure, and integrity. Its
upregulation by both Huh7 cells therefore shows that H.
bilis aﬀected basic cellular functions including cell morpho-
genesis. Upregulation of ACTB has also been reported in
HCV-induced HCC [51]a sw e l la si no t h e rc a n c e rt y p e s
[52, 53], suggesting a carcinogenic eﬀect of H. bilis. An
a c t i nr e l a t e dp r o t e i n2 / 3c o m p l e xs u b u n i t5( A R P C 5 )w a s
also upregulated in the transfected Huh7 cells but was
downregulated by the cured Huh7 cells, and tubulin beta
(TUBB)wasdownregulatedinthetransfectedHuh7cellsbut
was upregulated in the cured Huh7 cells. The modulation
of cytoskeletal proteins by the transfected- and cured Huh7
cells suggested a response to cytoskeletal stress that could
disrupt the normal functioning of Huh7 cells and may result
in the cells losing their ability to regulate shape and volume.
This stress can promote abnormalities in cell morphology
that lead to cell death, and help to explain the observed
hummingbird morphology and decrease in cell proliferation
observed in the Huh7-derived cell lines cocultured with H.
bilis.
Further, the modulation of TUBB indicated that the
bacterium aﬀected gap junction formations in both Huh7-
derived cell lines. Gap junctions are connections between
cytoplasm of two adjacent cells that make exchange of
molecules and ions possible [54], and these are regulated by
TUBB. In addition, TUBB is the building block of micro-
tubules, which form structural cytoskeleton. Hence its up
and downregulation in the cured- and transfected Huh7 cells
respectively suggested a structural change in the presence of
H. bilis. Similarly, modulation of ARPC5, a complex of the
actin-related proteins ARP2 and ARP3 able to regulate actin
polymerization [55], is another molecular event that could
contribute to the change in morphology of the hepatoma
cells in response to H. bilis.International Journal of Hepatology 11
3.8. Tumour-Related Proteins. Proteins that are associated
with tumourigenesis were identiﬁed among those regulated
in both the transfected- and cured Huh7 cells cocultured
with H. bilis. In the former, transformation upregulated
nuclear protein (HNRNP-K) was upregulated, together with
tumourproteinD52-like2isoformf(TPD52);C-MYCbind-
ing protein (MM1) was however downregulated in response
to H. bilis. In cured Huh7 cells, hepatoma-derived growth
factor (HDGF), rho GDP dissociation inhibitor alpha (GDI)
and prohibitin (PHB) were upregulated, but B23 nucle-
ophosmin (NPM) and DJ-1 protein (DJ-1) were downreg-
ulated in response to H. bilis.
HNRNP-K is highly upregulated in transformed cells. Its
speciﬁc role in cell transformation is still largely unclear, but
it is thought to be involved in cell cycle progression [56].
TPD52-like proteins are small coiled-coil motif bearing pro-
teins originally identiﬁed through their elevated expression
level in human breast carcinoma. It plays a role in calcium-
mediated signal transduction and cell proliferation [57,
58]. TPD52 also regulates mitosis and facilitates membrane
tethering and fusion through binding integral membrane
and membrane-associated proteins, and its deregulated
expressionmayaﬀectadverselycelldivisionandproliferation
[59].Theproteinisoverexpressedinmultiplehumancancers
[60, 61]. Its downregulation in the transfected Huh7 cells
could contribute to the observed decrease in cell prolifer-
a t i o ni nt h ep r e s e n c eo fH. bilis, and also suggested non-
tumourigenic eﬀects of H. bilis. The binding protein, MM1
is a pre-folding protein that binds to newly synthesized
cellular myelocytomatosis oncoprotein (C-MYC), stabilizing
and allowing it to fold correctly [62]. Its downregulation by
the transfected Huh7 cells suggested that C-MYC too may be
downregulated further indicating a non-tumourigenic eﬀect
of H.bilis.
In the cured Huh7 cell line, GDI, HDGF and PHB were
upregulated, and NPM and DJ-1 were downregulated. GDI
belongs to the family of Rho GDP dissociation inhibitors
that include RhoGDI, D4-GDI, and RhoGDI-3 [63]. They
regulate the reorganization of the actin cytoskeleton and
the integrity of associated integrin adhesion complexes
[63]. GDI is expressed ubiquitously and is directly involved
in cell adhesion. In breast cancer tissue, upregulation of
GDI has been linked to the induction of Raf-1, a protein
serine-threonine kinase, which plays a role in cell growth,
proliferation, and cell survival [64]. Thus, the upregulation
of GDI could be a tumourigenic response of the cured
Huh7 cell line to H. bilis. HDGF is an acidic heparin-bind-
ing protein originally isolated from the cultured media
of the Huh7 cell line [65]. It is expressed ubiquitously
in normal tissue and in tumour cell lines [66, 67]. The
protein has mitogenic eﬀect because recombinant HDGF
has been shown to stimulate the growth of a variety of
cells including hepatoma cells [65, 68, 69]. Studies have
indicated that HDGF participates in cellular proliferation
and diﬀerentiation [66, 70], and its increased expression has
been associatedwith poorly diﬀerentiated HCC celllines and
tumourprogressioninHCCspecimenswhereitisthoughtto
enhance the unregulated growth or recurrence of hepatoma
cells [71]. The downregulation of HDGF by the cured Huh7
c e l l si nc o c u l t u r e sw i t hH. bilis therefore did not indicate a
cancer-promoting response of the cell line to the presence of
the bacterium.
Prohibitin-PHB is localized in the mitochondria, is es-
sential for normal mitochondrial development, and plays
a role in tumour suppression, proliferation, cell-cycle pro-
gression, and apoptosis [72]. PHB also co-localises with
retinoblastoma protein (pRb) and P53, which are known
tumour suppressor proteins, and interacts with the tran-
scription factor E2F in various cell lines [73, 74]. These
observations indicate that PHB blocks cell proliferation
and acts as tumour suppressor by cell-cycle arrest via the
repression of E2F-mediated transcription [72, 75]. Dysreg-
ulation of PHB has not been documented in HCC, but its
upregulated expression has been reported in other human
cancer tissues and cell lines [76, 77]. The upregulation of
PHB suggested a tumour-suppression eﬀect of H. bilis on the
cured Huh7 cell line, and could account for the decrease of
Huh7 cells proliferation in the presence of the bacterium.
Many studies have suggested that NPM may be involved
in cancer pathogenesis [78], however, its physiological func-
tion in tumourigenesis is still controversial since this protein
has been ascribed both tumour suppressive and oncogenic
functions[78].ItsdownregulationincuredHuh7cellswould
reﬂect a cancer-promoting eﬀect of the bacterium. Func-
tionally, DJ-1 has been implicated in fertilization [79], the
regulation of androgen receptor signaling [80], and oxidative
stress [81]. In addition, DJ-1 is involved in apoptosis [82]
and cancer [83]. Its role in cancer is thought to involve the
suppression of the tumour suppressor PTEN which in turn
aﬀects the function of the protein kinase B (PKB/AKT),
a survival kinase [84]. The downregulation of DJ-1 would
enhance the suppression of PKB/AKT by PTEN leading to
a decrease in cell survival, a phenomenon that may help to
explain the observed reduction in cell proliferation of the
cured Huh7 cells in the presence of H. bilis and suggest
a nontumourigenic eﬀect of the bacterium on the cured
hepatoma cell line.
Additional investigations of the potential tumourigenic
eﬀectof H. bilis on the transfected- and cured Huh7 cell lines
were carried out by studying the diﬀerential expression of 16
HCC-related genes employing qRT-PCR (Figure 3).
Overall, the changes in the transcription of these HCC-
related genes diﬀered between transfected- and cured Huh7
cells exposed to H. bilis. The genes BAX and MCL-1
were downregulated in the transfected Huh7 cells but were
upregulated in the cured Huh7 cells in the presence of H.
bilis. Both genes belong to the B-cell lymphoma 2 family
of apoptotic proteins, BAX is proapoptotic while MCL-1 is
antiapoptotic, and their dysregulation has been associated
with HCC [85, 86]. The downregulation of BAX in the
transfected Huh7 cells would enhance cell survival; in
contrast, the downregulation of MCL-1 would enhance cell
death. On the other hand, the upregulation of BAX and
MCL-1 by the cured Huh7 cells would enhance cell death
and cell survival, respectively. Thus, the modulation of the
expressionofthesetwogenessuggestedacomplexregulation
of apoptosis in response to the presence of H. bilis which was
diﬀerent in both types of cells.12 International Journal of Hepatology
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Figure 3: Relative expression of HCC-related genes in transfected- & cured Huh7 cells in response to H. bilis. Values are presented as log2 of
the relative expression and represent the mean relative expression derived from biological triplicates. ∗P<0.05.
The oncogene KI-RAS was upregulated while C-MET,
C-MYC,a n dSTMN were downregulated by the trans-
fected Huh7 cells. KI-RAS belongs to the RAS family of
GTP-binding proteins and signals through the RAS/RAF/
MEK/ERKpathwaytoactivatethedownstreamtranscription
factors including NK-κB, CREB, AP-1, and C-MYC [87], all
of which have roles in regulating proliferation and apop-
tosis [88]. C-MET is a hepatocyte growth factor receptor
encoding tyrosine-kinase activity. C-MET also signals via
the RAS/RAF/MEK/ERK as well as the P13/AKT/PTEN
pathways [89]. In HCC, C-MET is an essential factor in the
process of migration and invasion of hepatocarcinoma cells
[90]. Thus, the downregulation of these eﬀector oncogenes,
regardless of the upregulation of KI-RAS, is consistent with
the proposition that H. bilis promoted anticancer activity in
the transfected Huh7 cells.
The cell proliferation regulators CCND-1, EGFR and
IGF-II were downregulated in the transfected Huh7 cells.
EGFR is a receptor for the transforming growth factor alpha
(TGF-α), a mitogenic growth factor required to trigger the
proliferative state. Expression of EGFR is associated with
HCC [91]; its inhibition induces growth arrest and apoptosis
in HCC cell lines [92] and prevents HCC development
in rats [93]. Thus, its downregulation would promote the
cell death of the transfected Huh7 cells. In addition, EGFR
together with IGF-II signal through the P13K/AKT/PTEN
and RAS/RAF/MEK/ERK pathways and promote the down-
stream activation of genes including the CCND1,t h u s ,
the downregulation of EGFR and IGF-II suggested an
antitumour response by the human cells and correlated with
the downregulation of CCND1 by the transfected Huh7
cells in response to H. bilis. CCND1 acts in concert with
cyclin-dependent kinase to phosphorylate and activate the
retinoblastoma protein (pRB), which is involved in cell
proliferation. Upregulation of CCND1 has been reported in
human and mice HCC tissues [94], thus, its downregulation
suggested also a nontumourigenic eﬀect of H. bilis on the
transfected Huh7 cells. In contrast, the downregulation of
the tumour suppressor gene ING1, whose product is a
nuclear protein that physically interacts with the tumor
suppressor protein TP53 in the p53-signaling pathway [95],
and can induce cell growth arrest and apoptosis, suggested a
tumourigenic eﬀectsof H. bilis on the transfected Huh7 cells.
4. Conclusion
Taken together, the diﬀerential expression of some tumour-
related proteins and HCC-associated genes provided evi-
dence for the carcinogenic eﬀects of H. bilis on the Huh7-
derived cell lines, although the expression pattern of other
proteins and genes did not support this conclusion. This
apparent contradiction may be explained by the fact that
hepatocarcinogenesis involves multiple factors and pathways
and are dependent on the carcinogen. Thus, it is possible
that Helicobacter spp. could initiate dysplasia in hepatocytes
through several processes some of which may not involve
known classical pathways in HCC development. The result
further shows that H. bilis exerted multiple stresses on both
the transfected and cured Huh7 cell lines, which appeared to
haveaﬀectedthefunctionofthemitochondriaandendoplas-
mic reticulum. At the molecular level, the transfected Huh7
celllineexpressedgeneswhichindicatedthatthecelllinewas
more susceptible to the eﬀect of the bacterium than to the
cured Huh7 cell line. Thus, it is possible that H. bilis could
potentiate the development from dysplasia to neoplasia of
the liver cells in the background of HCV-infection. The
similarities between the transfected and cured Huh7 cell
lines in the modulation of proteins belonging to biologicalInternational Journal of Hepatology 13
functional categories, some of which are implicated in cell
necrosis, revealed some common response of both cell lines
to the presence of H. bilis regardless of the presence of the
HCV-replicon in the transfected-cells, and suggested that the
bacterium could initiate preneoplastic processes in these cell
lines.
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